FDA Recalls Over 7,000 Antidepressant Bottles Due to Cancerous Content

The U.S. Food and Drug Administration (FDA) announced the recall of more than 7,000 bottles of antidepressants due to toxic chemicals.

Returns began earlier this month on October 10

Duloxetine, known by names such as Cymbalta, is reportedly used to treat mental illnesses such as anxiety and depression, according to the Cleveland Clinic.

The product is sold nationwide and is manufactured by Donghe Pharmaceutical Europe.

The agency noted the medication had the "presence" of nitrosamine drug substance impurity, N-nitroso-duloxetine.

According to the FDA, nitrosamine impurities "may increase the risk of cancer if humans are exposed to nitrosamine impurities for long periods above acceptable levels."

But he added: "If a person takes nitrosamine-containing drugs at or below the recommended daily allowance every day for 70 years, there is no expectation of developing cancer."

The report noted that 7,107 bottles (including 500 bottles of the anti-inflammatory drug) were recalled. is a FDA said is classified as Class II, meaning exposure to it could cause "temporary or irreversible adverse health effects."

The report noted that 7,107 bottles (including 500 bottles of the anti-inflammatory drug) were recalled. is a FDA said is classified as Class II, meaning exposure to it could cause "temporary or irreversible adverse health effects."